GHDX Financial Facts

Diluted net income (loss) per share (in dollars per share): -0.31
Income (loss) before income taxes: -9.25M
See Full Income Statement

Total liabilities and stockholders' equity: 177.03M
Accumulated other comprehensive loss: 12K
See Full Balance Sheet

Genomic Health Inc. (GHDX) Earnings

  |   Expand Research on GHDX
Next EPS Date 5/5/14 *Est. EPS Growth Rate -600.0% *Last Qtr.
Average EPS % Beat Rate -193.8% Revenue Growth Rate +13.9% *Last Qtr.
Average % Move 1-Wk after EPS +0.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/4/14 Q413 -$0.30-$0.03 -$0.27$68.8M$69.2M = -9.1% Details
11/5/13 Q313 $0.02-$0.04 +$0.06$66M$64.98M = 0% Details
7/31/13 Q213 -$0.10-$0.08 -$0.02$63.7M$63.91M = -24.8% Details
5/2/13 Q113 -$0.03-$0.03 $0.00$62.7M$62.9M = -11.8% Details
2/6/13 Q412 $0.06$0.03 +$0.03$60.4M$58.9M = -6.4% Details
11/7/12 Q312 $0.11$0.05 +$0.06$58.6M$59.85M N/A -16.2% Details
8/8/12 Q212 $0.06-$0.02 +$0.08$57.6M$58.24M = -14.4% Details
5/2/12 Q112 $0.02-$0.03 +$0.05$58.58M$56.27M = -8.3% Details